Cargando…

Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder

CDKL5 deficiency disorder (CDD), a rare and severe neurodevelopmental disease caused by mutations in the X-linked CDKL5 gene, is characterized by early-onset epilepsy, intellectual disability, and autistic features. Although pharmacotherapy has shown promise in the CDD mouse model, safe and effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tassinari, Marianna, Mottolese, Nicola, Galvani, Giuseppe, Ferrara, Domenico, Gennaccaro, Laura, Loi, Manuela, Medici, Giorgio, Candini, Giulia, Rimondini, Roberto, Ciani, Elisabetta, Trazzi, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369425/ https://www.ncbi.nlm.nih.gov/pubmed/35955854 http://dx.doi.org/10.3390/ijms23158719

Ejemplares similares

Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder
por: Galvani, Giuseppe, et al.
Publicado: (2021)

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
por: Mottolese, Nicola, et al.
Publicado: (2023)

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder
por: Loi, Manuela, et al.
Publicado: (2021)

Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder
por: Medici, Giorgio, et al.
Publicado: (2022)

Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
por: Loi, Manuela, et al.
Publicado: (2023)

Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist
por: Ren, Elisa, et al.
Publicado: (2019)

Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder
por: Fuchs, Claudia, et al.
Publicado: (2018)

Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death
por: Gennaccaro, Laura, et al.
Publicado: (2021)

Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder
por: Fuchs, Claudia, et al.
Publicado: (2022)

CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells
por: Valli, Emanuele, et al.
Publicado: (2012)

Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling
por: Fuchs, Claudia, et al.
Publicado: (2014)

Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder
por: Lupori, Leonardo, et al.
Publicado: (2019)

Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder
por: Ruggiero, Valeria, et al.
Publicado: (2023)

Mapping Pathological Phenotypes in a Mouse Model of CDKL5 Disorder
por: Amendola, Elena, et al.
Publicado: (2014)

Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice
por: Mazziotti, Raffaele, et al.
Publicado: (2017)

Reigning in Excitatory Signaling in CDKL5 Deficiency
por: Forcelli, Patrick A.
Publicado: (2019)

Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder
por: Varela, Tatiana, et al.
Publicado: (2022)

Cortical Visual Impairment in CDKL5 Deficiency Disorder
por: Quintiliani, Michela, et al.
Publicado: (2022)

Novel preclinical model for CDKL5 deficiency disorder
por: Serrano, Rita J., et al.
Publicado: (2022)

Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
por: Katayama, Syouichi, et al.
Publicado: (2020)

Phenotypic characterization of Cdkl5-knockdown neurons establishes elongated cilia as a functional assay for CDKL5 Deficiency Disorder
por: Di Nardo, Alessia, et al.
Publicado: (2022)

CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy
por: Jakimiec, Martyna, et al.
Publicado: (2020)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
por: Saby, Joni N, et al.
Publicado: (2022)

CDKL5 Deficiency Disorder (CDD)—Rare Presentation in Male
por: Rodak, Małgorzata, et al.
Publicado: (2022)

Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder
por: Vossler, David G.
Publicado: (2022)

Luteolin ameliorates loperamide-induced functional constipation in mice
por: Wang, Yujin, et al.
Publicado: (2023)

Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
por: Kadam, Shilpa D., et al.
Publicado: (2019)

Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
por: Olson, Heather E., et al.
Publicado: (2021)

Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders
por: Yan, Yumei, et al.
Publicado: (2020)

Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
por: Impellizzeri, Daniela, et al.
Publicado: (2013)

Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model
por: WANG, HUIMIN, et al.
Publicado: (2016)

The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
por: Trovò, L., et al.
Publicado: (2020)

Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome
por: Giacomini, Andrea, et al.
Publicado: (2015)

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder
por: Amin, Sam, et al.
Publicado: (2022)

Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
por: Wong, Kingsley, et al.
Publicado: (2022)

CDKL5 deficiency disorder: progressive brain atrophy may be part of the syndrome
por: Specchio, Nicola, et al.
Publicado: (2023)

Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

There is variability in the attainment of developmental milestones in the CDKL5 disorder
por: Fehr, Stephanie, et al.
Publicado: (2015)

Characterisation of CDKL5 Transcript Isoforms in Human and Mouse
por: Hector, Ralph D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bl2iufhh06fuckqrd56r7ml2rr